Muthusamy R.ph. on medical technology
From Pure Vu Review - Dr Muthusamy Episode 2 · · MotusGI
“Using PureVu technology, we were able to improve a patient's prep score from suboptimal to excellent, enabling a thorough exam that avoided missed lesions and the need for repeat procedures, which benefits both patient outcomes and healthcare costs.”
On , Muthusamy R.ph., Head of R&D, Chief Operating Officer of New Jersey Operations & Director at ANI PHARMACEUTICALS INC, spoke about medical technology during Pure Vu Review - Dr Muthusamy Episode 2 on MotusGI.
About Muthusamy R.ph.
In a September 2020 interview, Dr. Raman Muthusamy, medical director of endoscopy at UCLA Health, discussed challenges with bowel preparation for colonoscopy in hospitalized patients. He described scenarios where patients cannot drink prep due to medical conditions, requiring nasogastric tube instillation, and noted that impaired motility and narcotic use can prolong the prep process. Muthusamy stated that inadequate bowel prep can obscure subtle lesions behind large folds in the colon, increasing the risk of missed findings. He also mentioned a theoretical risk of combustible gases in the colon igniting during electric cautery, particularly for large polyp removal, which he said motivates careful attention to adequate prep. Muthusamy discussed the use of PureVu technology in both inpatient and outpatient settings. He said that for inpatients, suboptimal prep quality often leads to repeat exams, additional costs, and resource use. He described a case where PureVu improved a patient's prep score from suboptimal to excellent, allowing a thorough exam that avoided a missed lesion and the need for a repeat procedure. For outpatients traveling long distances, he noted that inadequate prep can require additional trips or hotel stays, adding financial and logistical burdens.